Status:
COMPLETED
Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Obesity
Short Stature
Eligibility:
All Genders
Up to 18 years
Brief Summary
Obesity, now a global epidemic, is a leading cause of illness and mortality in the developed world. To better understand the pathophysiological mechanisms that underlie weight disorders, increasing at...
Detailed Description
Background: Obesity, now a global epidemic, is a leading cause of illness and mortality in the developed world. To better understand the pathophysiological mechanisms that underlie weight disorders, i...
Eligibility Criteria
Inclusion
- Group1: Children with GH deficiency diagnosed by 2 provocative tests with peak GH less than 10 ng/ml.
- Group 2:Children with height less than the 3rd centile without any etiology
- Group 3:children with failure to thrive until the age of 3 years.
- Group 4: children with obesity defined by BMI above the 90th centile for age and sex.
- Group 5: children with no endocrine diseases and without obesity or short stature.
Exclusion
- Children with known pediatric or endocrine diseases.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT00830141
Start Date
January 1 2009
End Date
January 1 2012
Last Update
July 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.